Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis

No abstract is available for this paper.

• Publication year

  1997

• Venue

  British Journal of Ophthalmology

• Publication date

  1997-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bjo.81.1.23PMID 9135403PMCID PMC1721999
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tear Histamine and Histaminase during the Early (Epr) and Late (Lpr) Phases of the Allergic Reaction and the Effects of Lodoxamide

  1996cited by this paper
• Collagen types I and III in giant papillae of vernal keratoconjunctivitis.

  1995cited by this paper
• Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis

  1995cited by this paper
• Increased serum levels of eosinophil cationic protein and eosinophil-derived neurotoxin (protein X) in vernal keratoconjunctivitis.

  1994cited by this paper
• The eye and the eosinophil.

  1994cited by this paper
• Efficacy of lodoxamide 0.1% ophthalmic solution in resolving corneal epitheliopathy associated with vernal keratoconjunctivitis.

  1994cited by this paper
• Eosinophil granule major basic protein deposition in corneal ulcers associated with vernal keratoconjunctivitis.

  1993cited by this paper
• Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitis.

  1992cited by this paper
• Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis.

  1991cited by this paper
• Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis.

  1990cited by this paper
• The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients.

  1988cited by this paper
• The eye and immunology

  1982cited by this paper
• Immunological investigations in vernal eye disease.

  1980cited by this paper
• Randomized clinical trial of topically administered cromolyn sodium for vernal keratoconjunctivitis.

  1980cited by this paper
• Cationic proteins of human granulocytes. VI. Effects on the complement system and mediation of chemotactic activity.

  1975cited by this paper
• Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid cells.

  1974cited by this paper
• Immediate Hypersensitivity in the Guinea Pig Conjunctiva

  1974cited by this paper

• Drug-eluting nanofibrous wound dressings composed of polycaprolactone and gelatin augment diabetic wounds healing via reducing oxidative stress and inflammation: An in vitro and in vivo study

  2024cites this paper
• Sustained Delivery of Olopatadine from Vitamin-E Loaded Contact Lenses

  2024cites this paper
• Safety and efficacy of sodium cromoglycate-fluorometholone fixed combination eye drops in allergic conjunctivitis

  2022cites this paper
• Efficacy of medical treatments for vernal keratoconjunctivitis: a systematic review and meta-analysis.

  2021cites this paper
• Immunopharmacology in Vernal Keratoconjunctivitis: Current and Future Perspectives

  2021cites this paper
• Atopic keratoconjunctivitis

  2020cites this paper
• Vernal Keratoconjunctivitis: an update focused on clinical grading system

  2019cites this paper
• Office-based ocular procedures for the allergist.

  2019cites this paper
• Vernal Keratoconjunctivitis.

  2019cites this paper
• The Study of Interleukin-17 Level in Vernal Keratoconjunctivitis Disease and its Relationship between Symptom and Sign Severity

  2017cites this paper
• Diagnostic tools in ocular allergy

  2017cites this paper
• 54 – Allergic and Immunologic Eye Disease

  2016cites this paper
• An Update on the Therapeutic Approach to Vernal Keratoconjunctivitis

  2016cites this paper
• Prevalence of various types of allergens in ocular allergic conditions of patients from Pokhara, Nepal

  2014cites this paper
• Vernal keratoconjunctivitis: A severe allergic eye disease with remodeling changes

  2014cites this paper
• Tear Eosinophil Cationic Protein Levels in Allergic Keratoconjunctivitis

  2014cites this paper
• [Biomarkers in allergic conjunctival diseases].

  2013cites this paper
• Management of Vernal Keratoconjunctivitis

  2013cites this paper
• Specific IgE in Tear Fluid and Features of Allergic Conjunctivitis

  2013cites this paper
• Allergy and allergic mediators in tears.

  2013cites this paper
• Relation Between Total Tear IgE and Severity of Acute Seasonal Allergic Conjunctivitis

  2012cites this paper
• Modern Approach to Managing Vernal Keratoconjunctivitis

  2010cites this paper
• Vernal keratoconjunctivitis: a major review

  2009cites this paper
• Evaluation of novel scoring system named 5-5-5 exacerbation grading scale for allergic conjunctivitis disease.

  2009cites this paper
• Therapeutische Optionen bei Keratoconjunctivitis vernalis

  2009cites this paper
• Ocular Allergy: Clinical, Therapeutic and Drug Discovery Considerations

  2008cites this paper
• Demographic aspects of allergic ocular diseases and evaluation of new criteria for clinical assessment of ocular allergy

  2008cites this paper
• EFFICACY OF KETOTIFEN FUMARATE 0.025% EYE DROPS IN TREATMENT OF VERNAL KERATOCONJUNCTIVITIS

  2008cites this paper
• Antihistamines and Mast Cell Stabilizers in Allergic Ocular Disease

  2008cites this paper
• Ocular allergy treatment.

  2008cites this paper
• Ocular allergy overview.

  2008cites this paper
• New drug treatments for ocular allergies

  2007cites this paper
• Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in vernal keratoconjunctivitis patients

  2007cites this paper
• Rapid Responses

  2007cites this paper
• Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis

  2007cites this paper
• IMMUNOLOGY OF ALLERGIC EYE DISEASE

  2006cites this paper
• Allergic diseases of the eye.

  2006cites this paper
• Pharmacology of ocular allergy

  2006cites this paper
• THE EFFECTIVENESS TEST OF EYEDROP LODOXAMIDE TROMETHAMINE 0.1 % AND SODIUM CROMOGLYCATE 2% IN VERNAL KERATOCONJUNCTIVITY IN DR. SOETOMO HOSPITAL, SURABAYA

  2005cites this paper
• Emerging drugs for ocular allergy

  2005cites this paper
• The promotion of eosinophil degranulation and adhesion to conjunctival epithelial cells by IgE-activated conjunctival mast cells.

  2004cites this paper
• Myeloperoxidase Release After Allergen‐Specific Conjunctival Challenge

  2004cites this paper
• Tear and Serum Eosinophil Cationic Protein Levels in Seasonal Allergic Conjunctivitis

  2003cites this paper
• Vernal Keratoconjunctivitis

  2003cites this paper
• Efficacy of tear eosinophil cationic protein level measurement using filter paper for diagnosing allergic conjunctival disorders.

  2003cites this paper
• Inhibitory effects of ketotifen on eotaxin‐dependent activation of eosinophils: consequences for allergic eye diseases

  2003cites this paper
• Topical immunopharmacology of ocular allergies

  2002cites this paper
• Vernal keratoconjunctivitis: pathogenesis and treatment.

  2002cites this paper
• Tear osteopontin levels in patients with allergic conjunctival diseases

  2002cites this paper
• Efficacy of topical lodoxamide vs sodium cromoglycate and dexamethasone in rabbits with passive allergic conjunctivitis

  2002cites this paper
• Update on ocular allergy treatment

  2002cites this paper
• Comparison of Lodoxamide 0.1% Ophthalmic Solution and Levocabastine 0.05% Ophthalmic Suspension in Vernal Keratoconjunctivitis

  2001influential citation
• Cyclosporine Effects on Clinical Findings and Impression Cytology Specimens in Severe Vernal Keratoconjunctivitis

  2001cites this paper
• Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases.

  2000cites this paper
• Allergic and immunologic disorders of the eye. Part II: ocular allergy.

  2000cites this paper
• The effects of systemic medication on ocular allergic disease.

  2000cites this paper
• Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis.

  2000cites this paper
• Pharmacology of the eosinophil.

  1999cites this paper
• The treatment of allergic eye disease: has sodium cromoglycate had its day?

  1999cites this paper
• Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease

  1999cites this paper
• Effects of lodoxamide, disodium cromoglycate and fluorometholone on tear leukotriene levels in vernal keratoconjunctivitis

  1998cites this paper
• An overview of the current drugs scene

  1998cites this paper